Theranostics 2017; 7(13):3306-3318. doi:10.7150/thno.20242 This issue Cite

Research Paper

A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid

Yanqin Liang1, 2*, Suxin Li2*, Xiaoyou Wang2, Bo He2, Bing He2, Wenbing Dai2, Hua Zhang2, Xueqing Wang2, Yiguang Wang1, 2, Demin Zhou1, Qiang Zhang1, 2✉

1. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China;
2. Beijing Key Laboratory of Molecular Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
* Both authors contributed equally to this manuscript.

Citation:
Liang Y, Li S, Wang X, He B, He B, Dai W, Zhang H, Wang X, Wang Y, Zhou D, Zhang Q. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid. Theranostics 2017; 7(13):3306-3318. doi:10.7150/thno.20242. https://www.thno.org/v07p3306.htm
Other styles

File import instruction

Abstract

Graphic abstract

To design a prodrug-based self-assembling nanosystem with both ligand targeting and stimuli-responsive features, and elucidate the superiority of each targeting strategy and the synergistic effect between them, we synthesized four small molecule amphiphilic peptide-drug conjugates (APDCs) using maytansinoid (DM1) as a cytotoxic agent, cRGDfK as a homing peptide, and disulfide (SS) or thioether (SMCC) as linker. Owing to their amphiphilicity, the APDCs could self-assemble into nanoparticles (APDC@NPs) which were evaluated in vitro in three different cell lines and in vivo in tumor-bearing C57BL/6 mice. The RSSD@NPs showed the strongest interaction with αvβ3 integrin, highest cell uptake and intracellular free drug level, and best antitumor efficacy in vitro and in vivo, while it shared the same goodness with other test nanosystems in terms of high drug loading, EPR effect and free of potentially toxic polymers. Especially, the in vivo efficacy of RSSD@NPs was 2 fold of free DM1 which is too cytotoxic to be a drug, while the active targeted APDC@NPs demonstrated acceptable system, tissue and blood compatibility. In αvβ3-positive cells or tumors, the RGD targeting contributed much more than disulfide in anticancer effect. The maximum synergism of the two strategies reached to 22 fold in vitro and 3 fold in vivo. Generally, the active targeting, prodrug and nanosystem could significantly decrease the toxicity of free DM1 and improve its therapy outcome via combining active targeting, prodrug and nanopreparation, especially the dual targeting strategies and their synergism.

Keywords: Amphiphilic peptide-drug conjugate, αvβ3-targeted nanoparticles, reduction-triggered drug release, maytansinoid DM1, endocytosis, antitumor therapy.


Citation styles

APA
Liang, Y., Li, S., Wang, X., He, B., He, B., Dai, W., Zhang, H., Wang, X., Wang, Y., Zhou, D., Zhang, Q. (2017). A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid. Theranostics, 7(13), 3306-3318. https://doi.org/10.7150/thno.20242.

ACS
Liang, Y.; Li, S.; Wang, X.; He, B.; He, B.; Dai, W.; Zhang, H.; Wang, X.; Wang, Y.; Zhou, D.; Zhang, Q. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid. Theranostics 2017, 7 (13), 3306-3318. DOI: 10.7150/thno.20242.

NLM
Liang Y, Li S, Wang X, He B, He B, Dai W, Zhang H, Wang X, Wang Y, Zhou D, Zhang Q. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid. Theranostics 2017; 7(13):3306-3318. doi:10.7150/thno.20242. https://www.thno.org/v07p3306.htm

CSE
Liang Y, Li S, Wang X, He B, He B, Dai W, Zhang H, Wang X, Wang Y, Zhou D, Zhang Q. 2017. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid. Theranostics. 7(13):3306-3318.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image